Uncategorized
The regulation of Orphan Medicinal products takes place in the US at the FDA and in the European Union at the EMEA.
Useful Links
Not Found
Sorry, but you are looking for something that isn't here.
Rare Disease Blogs
International opinion on Rare Diseases & Orphan Drugs
